TTRX

Turn Therapeutics
TTRX

3.61 USD
-0.12
3.22%
At close Updated Mar 13, 4:00 PM EDT
Pre-market
After hours
3.49
-0.12
3.32%
1 day
-3.22%
5 days
4.94%
1 month
2.85%
3 months
17.21%
6 months
-48.43%
Year to date
-23.03%
1 year
-48.43%
5 years
-48.43%
10 years
-48.43%
 

About: Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Healthcare Biotechnology
0
Funds holding %
of 8,077 funds
Explore Fund Trends
0
Analysts bullish %
of 1 analysts
See Analyst Outlook
–
Positive news %
of articles
Check Journalist POV
Price charts implemented using Lightweight Charts™